$EL

La Lande Rashida sold $802K of EL

La Lande Rashida (Exec VP & General Counsel) sold 7,766 shares of ESTEE LAUDER COMPANIES INC (EL) at $103.32 ($0.80M total) on 2026-08-28.

Original reporting
SEC EDGAR · La Lande Rashida
Published Aug 31, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EL
Neutral
medium confidence
Mentioned
$EL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ELNeutralLow
01

Why it matters

The sale reduces insider ownership to zero, which may be noted by analysts but unlikely to move the stock significantly.

02

Market read

Primary insider sale filing; modest size limits market impact.

03

What to watch

Potential tax-driven sale or diversification; no indication of material insider concern.

Relevance 5/10Novelty 5/10Timing: post-market 2026-08-28

Background

SEC Form 4 filing discloses insider transactions; required for officers and directors.

Company-level read

Ticker impact

$ELNeutralMedium confidence
Context

Exec VP & General Counsel La Lande Rashida sold 7,766 shares for $802,383, reducing holdings to zero.

Expected impact

Potential short-term pressure on EL stock, likely limited to a few basis points.

Evidence & confidence

Form 4 filing is primary source; $0.8M sale is small for a large cap, so impact is modest.

Market effects

Minimal effect on cosmetics sector; insider activity typical.

U.S. market only; no broader regional impact.

Low global relevance.

Counterpoint

Sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Estee Lauder Companies Inc.

    US-listed cosmetics giant (ticker EL).

  • La Lande Rashida

    Executive Vice President & General Counsel.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ELMed

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.